ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JENNIFER WEBER ANP-C

At A Glance: This Prescriber in 2012

Nurse Practitioner, Adult Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 129

$425K Total Retail Price of All Prescriptions

Rank: 6 out of 129

197 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 197 patients filled at least one prescription for a schedule two drug, compared to an average of 17%.

Schedule Three
Controlled Substances

16% of this provider’s 197 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 451 399 1 2
LISINOPRIL 316 277 2 1
OMEPRAZOLE 313 252 3 12
SIMVASTATIN 280 229 4 5
FUROSEMIDE 263 192 5 9
WARFARIN SODIUM 240 150 6 7
GABAPENTIN 227 131 7 11
DONEPEZIL HCL 211 198 8 19
CITALOPRAM HBR 195 154 9 16
METOPROLOL TARTRATE 175 124 10 10
AMLODIPINE BESYLATE 170 154 11 8
RISPERIDONE 166 150 12 25
SERTRALINE HCL 166 109 12 24
HYDROCODONE-ACETAMINOPHEN 123 70 S3 14 3
NAMENDA 119 119 15 38
TRAZODONE HCL 115 76 16 20
LANTUS 107 66 17 22
ISOSORBIDE MONONITRATE ER 94 78 18 42
POTASSIUM CHLORIDE 93 55 19 29
MORPHINE SULFATE ER 91 47 S2 20 4
OXYBUTYNIN CHLORIDE 90 87 21 83
DIVALPROEX SODIUM 84 58 22 36
METOPROLOL SUCCINATE 82 70 23 18
KLOR-CON M20 78 78 24 65
PANTOPRAZOLE SODIUM 77 71 25 62
TRAMADOL HCL 77 70 25 39
KLOR-CON M10 76 42 27 93
FLUOXETINE HCL 75 61 28 71
CARVEDILOL 73 72 29 13
ADVAIR DISKUS 73 50 29 73
ALENDRONATE SODIUM 70 44 31 56
METFORMIN HCL 70 42 31 14
LEVETIRACETAM 67 29 33 58
CLOPIDOGREL 66 63 34 34
HYDROCHLOROTHIAZIDE 64 63 35 28
NOVOLOG 63 34 36 79
PAROXETINE HCL 61 58 37 75
RANITIDINE HCL 60 52 38 45
INSULIN SYRINGE 57 44 39 33
SPIRONOLACTONE 56 49 40 86
BACLOFEN 56 16 40 54
CLONIDINE HCL 55 46 42 66
FLUTICASONE PROPIONATE 53 31 43 72
DIOVAN 52 52 44 70
CYMBALTA 52 37 44 51
ATENOLOL 50 50 46 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.